Taming the chronic kidney disease epidemic: a global view of surveillance efforts.

[1]  T. Andreoli.  About Kidney International. , 1985, Kidney international.

[2]  Y. Ohashi,et al.  Chronic Kidney Disease Japan Cohort study: baseline characteristics and factors associated with causative diseases and renal function , 2010, Clinical and Experimental Nephrology.

[3]  W. Hoy,et al.  CKD.QLD: chronic kidney disease surveillance and research in Queensland, Australia , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  Craig E. Nelson,et al.  Factors associated with the progression of chronic kidney disease in nephrology practices in Australia: A retrospective analysis using management software (audit4) , 2011 .

[5]  V. Jha,et al.  Chronic kidney disease: global dimension and perspectives , 2013, The Lancet.

[6]  Y. Ohashi,et al.  Management of anemia in chronic kidney disease patients: baseline findings from Chronic Kidney Disease Japan Cohort Study , 2011, Clinical and Experimental Nephrology.

[7]  G. Remuzzi,et al.  The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. , 2011, Kidney international.

[8]  J. Mindell,et al.  Prevalence of chronic kidney disease in England: Findings from the 2009 Health Survey for England , 2011, Journal of Epidemiology & Community Health.

[9]  Y. Ohashi,et al.  Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease: findings from the CKD-JAC study , 2018, Clinical and Experimental Nephrology.

[10]  R. Fassett,et al.  Factors Associated with Chronic Kidney Disease Progression in Australian Nephrology Practices , 2012, Nephron Clinical Practice.

[11]  Y. Ohashi,et al.  Clinical correlates of ambulatory BP monitoring among patients with CKD. , 2013, Clinical journal of the American Society of Nephrology : CJASN.

[12]  Bernadette A. Thomas,et al.  Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[13]  Y. Ohashi,et al.  Chronic Kidney Disease Japan Cohort (CKD-JAC) Study: Design and Methods , 2008, Hypertension Research.

[14]  Brenda R. Hemmelgarn,et al.  Notice , 2012, Kidney International Supplements.

[15]  David W Dunstan,et al.  Prevalence of kidney damage in Australian adults: The AusDiab kidney study. , 2003, Journal of the American Society of Nephrology : JASN.

[16]  N. Powe,et al.  Establishing a national chronic kidney disease surveillance system for the United States. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[17]  Corri Black,et al.  Measuring the population burden of chronic kidney disease: a systematic literature review of the estimated prevalence of impaired kidney function. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[18]  W. G. Walker,et al.  Plasma aldosterone regulation in anephric man. , 1973, Kidney international.

[19]  J. Feehally.  Chronic kidney disease: Health burden of kidney disease recognized by UN , 2012, Nature Reviews Nephrology.

[20]  R. Ward.  NHS Kidney Care , 2011 .

[21]  D. Rothenbacher,et al.  Prevalence of chronic kidney disease in population-based studies: Systematic review , 2008, BMC public health.

[22]  P. Stevens,et al.  The impact of pay for performance on the control of blood pressure in people with chronic kidney disease stage 3-5. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[23]  Stephen Jan,et al.  How can we achieve global equity in provision of renal replacement therapy? , 2008, Bulletin of the World Health Organization.